Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cornelis J A Haasbeek

Showing results (1-10 of 59) with videos related to

Pageof 6
Sort By:
Lung Cancer (Amsterdam, Netherlands)|September 6, 2008
Radiotherapy for lung cancer: clinical impact of recent technical advancesCornelis J A Haasbeek, Ben J Slotman, Suresh Senan
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|March 7, 2013
Outcomes of stereotactic ablative radiotherapy for central lung tumours: a systematic reviewSashendra Senthi, Cornelis J A Haasbeek, Ben J Slotman, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|September 6, 2011
Outcomes of stereotactic ablative radiotherapy for centrally located early-stage lung cancerCornelis J A Haasbeek, Frank J Lagerwaard, Ben J Slotman, et al.
Radiology|December 22, 2007
CT-guided pulmonary radiofrequency ablationCornelis J A Haasbeek, Suresh Senan, Egbert F Smit, et al.
The Lancet. Oncology|June 26, 2012
Patterns of disease recurrence after stereotactic ablative radiotherapy for early stage non-small-cell lung cancer: a retrospective analysisSashendra Senthi, Frank J Lagerwaard, Cornelis J A Haasbeek, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|November 8, 2011
Outcomes of stereotactic ablative radiotherapy following a clinical diagnosis of stage I NSCLC: comparison with a contemporaneous cohort with pathologically proven diseaseNaomi E Verstegen, Frank J Lagerwaard, Cornelis J A Haasbeek, et al.
International Journal of Radiation Oncology, Biology, Physics|February 6, 2007
Is adaptive treatment planning required for stereotactic radiotherapy of stage I non-small-cell lung cancer?Cornelis J A Haasbeek, Frank J Lagerwaard, Johan P Cuijpers, et al.
Cancer|January 9, 2009
Outcomes of stereotactic radiotherapy for a new clinical stage I lung cancer arising postpneumonectomyCornelis J A Haasbeek, Frank J Lagerwaard, Katrien de Jaeger, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|November 5, 2011
Incidence and risk factors for chest wall toxicity after risk-adapted stereotactic radiotherapy for early-stage lung cancerEva M Bongers, Cornelis J A Haasbeek, Frank J Lagerwaard, et al.
Cancer|December 2, 2009
Stage I nonsmall cell lung cancer in patients aged > or =75 years: outcomes after stereotactic radiotherapyCornelis J A Haasbeek, Frank J Lagerwaard, Marilisa E Antonisse, et al.
Pageof 6

Showing results (1-10 of 59) with videos related to

Sort By:
Pageof 6
Lung Cancer (Amsterdam, Netherlands)|September 6, 2008
Radiotherapy for lung cancer: clinical impact of recent technical advancesCornelis J A Haasbeek, Ben J Slotman, Suresh Senan
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|March 7, 2013
Outcomes of stereotactic ablative radiotherapy for central lung tumours: a systematic reviewSashendra Senthi, Cornelis J A Haasbeek, Ben J Slotman, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|September 6, 2011
Outcomes of stereotactic ablative radiotherapy for centrally located early-stage lung cancerCornelis J A Haasbeek, Frank J Lagerwaard, Ben J Slotman, et al.
Radiology|December 22, 2007
CT-guided pulmonary radiofrequency ablationCornelis J A Haasbeek, Suresh Senan, Egbert F Smit, et al.
The Lancet. Oncology|June 26, 2012
Patterns of disease recurrence after stereotactic ablative radiotherapy for early stage non-small-cell lung cancer: a retrospective analysisSashendra Senthi, Frank J Lagerwaard, Cornelis J A Haasbeek, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|November 8, 2011
Outcomes of stereotactic ablative radiotherapy following a clinical diagnosis of stage I NSCLC: comparison with a contemporaneous cohort with pathologically proven diseaseNaomi E Verstegen, Frank J Lagerwaard, Cornelis J A Haasbeek, et al.
International Journal of Radiation Oncology, Biology, Physics|February 6, 2007
Is adaptive treatment planning required for stereotactic radiotherapy of stage I non-small-cell lung cancer?Cornelis J A Haasbeek, Frank J Lagerwaard, Johan P Cuijpers, et al.
Cancer|January 9, 2009
Outcomes of stereotactic radiotherapy for a new clinical stage I lung cancer arising postpneumonectomyCornelis J A Haasbeek, Frank J Lagerwaard, Katrien de Jaeger, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|November 5, 2011
Incidence and risk factors for chest wall toxicity after risk-adapted stereotactic radiotherapy for early-stage lung cancerEva M Bongers, Cornelis J A Haasbeek, Frank J Lagerwaard, et al.
Cancer|December 2, 2009
Stage I nonsmall cell lung cancer in patients aged > or =75 years: outcomes after stereotactic radiotherapyCornelis J A Haasbeek, Frank J Lagerwaard, Marilisa E Antonisse, et al.
Pageof 6